omega-n-methylarginine has been researched along with Acute Coronary Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Béchir, M; Chenevard, R; Corti, R; Enseleit, F; Flammer, AJ; Hermann, M; Hürlimann, D; Lüscher, TF; Noll, G; Ruschitzka, F; Spieker, L; Sudano, I | 1 |
1 trial(s) available for omega-n-methylarginine and Acute Coronary Syndrome
Article | Year |
---|---|
Reconstituted HDL in acute coronary syndromes.
Topics: Acetylcholine; Acute Coronary Syndrome; Aged; Biomarkers; Double-Blind Method; Electrocardiography; Endothelium, Vascular; Enzyme Inhibitors; Female; Fibrinolytic Agents; Hemodynamics; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins, HDL; Male; Middle Aged; Nitroprusside; omega-N-Methylarginine; Oxidative Stress; Plethysmography; Vasculitis; Vasodilator Agents | 2012 |